Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats

Brain Research
A KaskJ Harro

Abstract

Neuropeptide Y (NPY, 1 and 10 pmol), NPY Y1 receptor agonist [Leu31, Pro34]NPY (10 pmol) and Y2 agonist NPY13-36 (100 pmol) were administered unilaterally into the region of the nucleus locus coeruleus (LC) in rats. NPY (10 pmol) and NPY13-36 increased the percentage of open arm entries, the percentage of time spent on open part, number of both open and closed arm entries and line crossings in the open part while [Leu31,Pro34]NPY failed to modify elevated plus-maze behavior. These data suggest that NPY applied close to LC has anxiolytic-like effects by acting on NPY Y2, not on Y1 receptors. Thus, NPY Y2 receptors in the vicinity of LC may be involved in the regulation of anxiety in rats.

References

Oct 1, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·E P FintaP Illes
Oct 1, 1991·Trends in Pharmacological Sciences·M C Michel
May 7, 1987·European Journal of Pharmacology·M Heilig, R Murison
Aug 1, 1985·Neuroscience·B M ChronwallT L O'Donohue
Aug 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·S L Handley, S Mithani
Jun 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M HeiligK T Britton
Nov 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·P IllesK Nieber
Jan 1, 1993·Annual Review of Pharmacology and Toxicology·C Wahlestedt, D J Reis
Jan 1, 1993·Journal of Psychopharmacology·R E Adamec, D McKay

❮ Previous
Next ❯

Citations

Feb 7, 2002·Pharmacology, Biochemistry, and Behavior·Tammy J SajdykDonald R Gehlert
Sep 6, 2003·Pharmacology, Biochemistry, and Behavior·Tim KarlStephan von Hörsten
May 30, 2002·Neuroscience and Biobehavioral Reviews·Ants KaskRémi Quirion
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Sep 8, 2004·Journal of Neuroscience Research·Gunnar SørensenDavid P D Woldbye
May 23, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Elif Engin, Dallas Treit
Sep 5, 2009·The Journal of Comparative Neurology·Amanda B RostkowskiJanice H Urban
Sep 4, 2007·Biochemical Pharmacology·Aviel Goodman
Dec 1, 2015·Neuropeptides·Esther L SabbanLidia I Serova
Jul 16, 2003·The European Journal of Neuroscience·Alexandra TschenettGünther Sperk
Dec 17, 2014·Neurobiology of Stress·Nicole M EnmanElisabeth J Van Bockstaele
Oct 15, 2011·Expert Opinion on Therapeutic Targets·Gang WuAleksander A Mathé
Jun 23, 2011·Pharmacology, Biochemistry, and Behavior·Natalie L Trent, Janet L Menard
Jul 6, 2016·Experimental Neurology·Sarah N SchmeltzerRenu Sah
Jun 19, 2016·Journal of Neuroendocrinology·A P BorrowR Yunes
Jul 4, 2018·Cephalalgia : an International Journal of Headache·Marta Vila-PueyoSimon Akerman
Aug 6, 2003·The Journal of Comparative Neurology·Michael L WolakJanice H Urban
Sep 6, 2007·Endocrine Reviews·M M Kamiji, A Inui
Feb 26, 2019·Frontiers in Behavioral Neuroscience·Roxanna J NahviEsther L Sabban
Jun 30, 2019·Annals of the New York Academy of Sciences·Chiso NwokaforEsther L Sabban

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.